IRIS
BONGIOVANNI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 487
NA - Nord America 482
SA - Sud America 100
EU - Europa 50
AF - Africa 12
Totale 1.131
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 447
SG - Singapore 159
CN - Cina 131
BR - Brasile 66
HK - Hong Kong 49
VN - Vietnam 32
BD - Bangladesh 29
IN - India 21
IT - Italia 20
MX - Messico 17
IQ - Iraq 13
AR - Argentina 9
VE - Venezuela 9
CA - Canada 8
RU - Federazione Russa 8
MY - Malesia 7
PH - Filippine 7
TR - Turchia 7
ID - Indonesia 6
PK - Pakistan 6
CO - Colombia 5
FR - Francia 5
AE - Emirati Arabi Uniti 4
JM - Giamaica 4
NP - Nepal 4
PE - Perù 4
SA - Arabia Saudita 4
EC - Ecuador 3
ES - Italia 3
MA - Marocco 3
NL - Olanda 3
ZA - Sudafrica 3
EG - Egitto 2
PR - Porto Rico 2
PY - Paraguay 2
RS - Serbia 2
UA - Ucraina 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CL - Cile 1
DE - Germania 1
EE - Estonia 1
ET - Etiopia 1
GB - Regno Unito 1
GT - Guatemala 1
HN - Honduras 1
JO - Giordania 1
KR - Corea 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LV - Lettonia 1
MN - Mongolia 1
PL - Polonia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 1.131
Salva come PNG Salva come JPEG
Città #
San Jose 328
Ashburn 67
Singapore 66
Beijing 53
Hong Kong 48
Mexico City 15
Ho Chi Minh City 10
New York 10
Hanoi 9
Baghdad 6
Santa Clara 5
Kuala Lumpur 4
Medellín 4
São Paulo 4
Amsterdam 3
Chandigarh 3
Chennai 3
Dhaka 3
Istanbul 3
Lima 3
Mumbai 3
Naples 3
Ninh Bình 3
Nocera Terinese 3
Asunción 2
Belford Roxo 2
Belgrade 2
Brampton 2
Brasília 2
Campinas 2
Curitiba 2
Córdoba 2
Da Nang 2
Delhi 2
Guarulhos 2
Karbala 2
Midrand 2
Montes Claros 2
Moscow 2
Newton 2
Ribeirão Preto 2
Riyadh 2
San Polo di Piave 2
Selçuklu 2
Abakan 1
Abidjan 1
Abu Dhabi 1
Addis Ababa 1
Aguadilla 1
Ahmedabad 1
Al Ain City 1
Almaty 1
Alta Floresta 1
Anchorage 1
Andaraí 1
Andradina 1
Araras 1
Arouca 1
Asheboro 1
Aurora 1
Bahía de Caráquez 1
Baltimore 1
Banjar Badung 1
Banyumas 1
Barcelona 1
Barinas 1
Bekasi 1
Belfort 1
Belo Horizonte 1
Belém 1
Bengaluru 1
Biên Hòa 1
Bocaiúva 1
Bom Jesus do Galho 1
Brooklyn 1
Cagliari 1
Cairo 1
Caivano 1
Calgary 1
Caloocan 1
Campo Grande 1
Campo Mourão 1
Canoas 1
Canton 1
Capão do Leão 1
Caracas 1
Carcassonne 1
Carmópolis de Minas 1
Carolina 1
Casablanca 1
Castries 1
Catanzaro 1
Chapecó 1
Chatham 1
Chesnee 1
Ciudad Guayana 1
Coruripe 1
Council Bluffs 1
Dakar 1
Dakhla 1
Totale 755
Salva come PNG Salva come JPEG
Nome #
mTOR inhibitor and bone-targeted drugs break the vicious cycle between clear-cell renal carcinoma and osteoclasts in an in vitro co-culture model 32
BOne HEalth ManagEment in Patients with Early Breast Cancer: A Retrospective Italian Osteoncology Center "Real-Life" Experience (BOHEME Study) 20
Systemic Inflammatory Indices in Second-Line Soft Tissue Sarcoma Patients: Focus on Lymphocyte/Monocyte Ratio and Trabectedin 20
A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomas 19
Development of a human preclinical model of osteoclastogenesis from peripheral blood monocytes co-cultured with breast cancer cell lines 19
Deciphering the Genomic Landscape and Pharmacological Profile of Uncommon Entities of Adult Rhabdomyosarcomas 18
Osteoblastic bone metastases from neuroendocrine tumor (NET) of unknown origin detected by 18fluorocholine PET/CT and its comparison with 68gallium-DOTATOC PET/CT: Case report and review of the literature 18
Phase-II Trials of Pazopanib in Metastatic Neuroendocrine Neoplasia (mNEN): A Systematic Review and Meta-Analysis 18
Myxofibrosarcoma primary cultures: molecular and pharmacological profile 18
A biomimetic 3D model of hypoxia-driven cancer progression. 18
High-grade transformation of a polymorphous adenocarcinoma of the salivary gland: a case report and review of the literature 17
Case Report: Adult NTRK-Rearranged Spindle Cell Neoplasm: Early Tumor Shrinkage in a Case With Bone and Visceral Metastases Treated With Targeted Therapy. 17
Investigation of receptor radionuclide therapy with 177Lu-DOTATATE in patients with GEP-NEN and a high Ki-67 proliferation index 17
111In-Pentetreotide (OctreoScan) scintigraphy in the staging of small-cell lung cancer: Its accuracy and prognostic significance 16
CSF-1 blockade impairs breast cancer osteoclastogenic potential in co-culture systems 16
Comment on 'Reorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: A nationwide Italian survey' by Alice Indini et al. 16
Long-lasting activity of trabectedin in refractory uterine leiomyosarcoma: A case report 16
Third- and further-line therapy in advanced non-small-cell lung cancer patients: An overview 16
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors 16
Activity of Eribulin in a primary culture of well-differentiated/dedifferentiated adipocytic sarcoma 16
Vitamin D receptor polymorphisms or serum levels as key drivers of breast cancer development? The question of the vitamin D pathway 15
Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET) 15
First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma 15
A Rationale for the Activity of Bone Target Therapy and Tyrosine Kinase Inhibitor Combination in Giant Cell Tumor of Bone and Desmoplastic Fibroma: Translational 15
Nationwide multidisciplinary consensus on the clinical management of Merkel cell carcinoma: a Delphi panel 15
Ten-year experience of the multidisciplinary Osteoncology Center 14
ALK-negative lung inflammatory myofibroblastic tumor in a young adult: A case report and literature review of molecular alterations 14
Myxofibrosarcoma landscape: diagnostic pitfalls, clinical management and future perspectives. 14
Is it possible to conduct clinical trials during a pandemic? The example of a trial of hydroxychloroquine. 14
Immunotherapy in malignant pleural mesothelioma: a long story ended in success 14
Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world study 14
Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas 14
Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas 14
Outcomes of platinum-sensitive small-cell lung cancer patients treated with platinum/etoposide rechallenge: A multi-institutional retrospective analysis 13
Peptide receptor radionuclide therapy in the management of gastrointestinal neuroendocrine tumors: Efficacy profile, safety, and quality of life 13
3-T magnetic resonance-guided high-intensity focused ultrasound (3 T-MR-HIFU) for the treatment of pain from bone metastases of solid tumors. 13
Establishment of a primary culture of patient-derived soft tissue sarcoma 13
Peptide receptor radionuclide therapy with177Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and18F-FDG PET 13
Activity and Safety of Immune Checkpoint Inhibitors in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis 13
177Lu-DOTATATE Efficacy and Safety in Functioning Neuroendocrine Tumors: A Joint Analysis of Phase II Prospective Clinical Trials 13
A Rationale for the Activity of Bone Target Therapy and Tyrosine Kinase Inhibitor Combination in Giant Cell Tumor of Bone and Desmoplastic Fibroma: Translational Evidences 13
Primary leiomyosarcoma of the bone: A case report and a review of the literature 13
First prospective data on breast cancer patients from the multicentre italian bone metastasis database 13
Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paraganglioma 12
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues 12
Characterization and Drug Sensitivity of a New High-Grade Myxofibrosarcoma Cell Line 12
Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumors. 12
Lineage-specific mechanisms and drivers of breast cancer chemoresistance revealed by 3D biomimetic culture 12
Immune Checkpoint Inhibitors With or Without Bone-Targeted Therapy in NSCLC Patients With Bone Metastases and Prognostic Significance of Neutrophil-to-Lymphocyte Ratio. 12
Outcome Analysis of First-line Somatostatin Analog Treatment in Metastatic Pulmonary Neuroendocrine Tumors and Prognostic Significance of 18FDG-PET/CT 12
Sequencing Treatments in Patients with Advanced Well-Differentiated Pancreatic Neuroendocrine Tumor (pNET): Results from a Large Multicenter Italian Cohort 12
177Lu-PRRT in advanced gastrointestinal neuroendocrine tumors: 10-year follow-up of the IRST phase II prospective study 11
Abstract 333: Development of a biomimetic 3D scaffold to study breast cancer bone metastasis 11
The potential role of the extracellular matrix in the activity of trabectedin in UPS and L-sarcoma: evidences from a patient-derived primary culture case series in tridimensional and zebrafish models. 11
Lipids and adipocytes involvement in tumor progression with a focus on obesity and diet 11
Dried blood and serum spots as a useful tool for sample storage to evaluate cancer biomarkers 11
Innovative approaches to establish and characterize primary cultures: An ex vivo 3D system and the zebrafish model 11
Management and potentialities of primary cancer cultures in preclinical and translational studies 11
“Cytokine gene polymorphisms and breast cancer susceptibility” 11
Lysyl oxidase engineered lipid nanovesicles for the treatment of triple negative breast cancer 11
"Evaluating the prognostic role of serum extracellular domain (ECD) of HER-2/neu (s-HER2) in patients (PTS) with early (E) breast cancer (BC)” 11
Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma. 10
Induction chemotherapy plus concomitant chemoradiotherapy in nasopharyngeal carcinoma: An updated network meta-analysis 10
The Role of Homologous Recombination Deficiency (HRD) in Renal Cell Carcinoma (RCC): Biology, Biomarkers, and Therapeutic Opportunities. 10
HRAS overexpression predicts response to Lenvatinib treatment in gastroenteropancreatic neuroendocrine tumors 10
Metastatic neuroendocrine neoplasia treatments in patients over 70 years of age 10
Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study 10
Clinical and translational implications of immunotherapy in sarcomas 10
Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509) 10
Peptide receptor radionuclide therapy in patients with metastatic progressive pheochromocytoma and paraganglioma: long-term toxicity, efficacy and prognostic biomarker data of phase II clinical trials 10
Identification of a novel RAB3IP-HMGA2 fusion transcript in an adult head and neck rhabdomyosarcoma 10
Development of a patient-derived xenograft (PDX) of breast cancer bone metastasis in a Zebrafish model 10
Editorial: From bench to bedside in gastric cancer: diagnosis, prognosis, and treatment, volume II 9
Prognostic and Predictive Role of Body Composition in Metastatic Neuroendocrine Tumor Patients Treated with Everolimus: A Real-World Data Analysis 9
temozolomide Alone or Combined with Capecitabine for the Treatment of Metastatic Neuroendocrine Neoplasia: A "Real-World" Data Analysis. Neuroendocrinology. 9
Metronomic capecitabine in gastroenteropancreatic neuroendrocrine tumors: A suitable regimen and review of the literature 9
Safety and Quality-of-Life Data from an Italian Expanded Access Program of Lenvatinib for Treatment of Thyroid Cancer. 9
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial 9
Weekly docetaxel (wDOC) for the treatment of metastatic breast cancer (MBC): A literature based meta-analysis 9
Trefoil factor-1 upregulation in estrogen-receptor positive breast cancer correlates with an increased risk of bone metastasis 9
“Evaluating the prognostic role of serum extracellular domain (ECD) of HER-2/neu (s-HER2) in patients (PTS) with metastatic (M) breast cancer (BC): results of an observational study” 9
Three-dimensional collagen-based scaffold model to study the microenvironment and drug-resistance mechanisms of oropharyngeal squamous cell carcinomas 9
Bocchini M, Nicolini F, Severi S, Bongiovanni A, Ibrahim T, Simonetti G, Grassi I, Mazza M. Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management-An Updated Review. 9
Theragnostic in neuroendocrine tumors. 9
Delta-like ligand 3 (DLL3): an attractive actionable target in tumors with neuroendocrine origin 9
Pleural effusion in a patient with metastatic gastrointestinal stromal tumor treated with imatinib: Case report 8
Belzutifan for Advanced Pheochromocytoma or Paraganglioma 8
Therapeutic strategies in advanced pheochromocytoma or paraganglioma 8
The effect of everolimus in an in vitro model of triple negative breast cancer and osteoclasts 8
“Regulatory cytokine gene polymorphisms and risk of colorectal carcinoma” 8
Comment on the Paper by Lemelin et al. Entitled "Elderly Patients with Metastatic Neuroendocrine Tumors Are Undertreated and Have Shorter Survival: The LyREMeNET Study". 8
Clinical role of filgrastim in the management of patients at risk of prolonged severe neutropenia: An evidence-based review 8
Recombinant granulocyte colony-stimulating factor (rG-CSF) in the management of neutropenia induced by anthracyclines and ifosfamide in patients with soft tissue sarcomas (NEUSAR) 7
Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors 7
SENECA Study Team Investigators. Randomised phase II trial of CAPTEM or FOLFIRI as SEcond-line therapy in NEuroendocrine CArcinomas and exploratory analysis of predictive role of PET/CT imaging and biological markers (SENECA trial): a study protocol 7
RANKL: A promising circulating marker for bone metastasis response 6
Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATE 6
Grading of neuroendocrine carcinomas: Correlation of 68 Ga-PET/CT scan with tissue biomarkers 6
Tumor-stroma crosstalk in bone tissue: The osteoclastogenic potential of a breast cancer cell line in a co-culture system and the role of EGFR inhibition 6
Primary culture of undifferentiated pleomorphic sarcoma: Molecular characterization and response to anticancer agents 6
Totale 1.220
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.058
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.058
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/20261.235 0 0 47 109 232 24 29 103 512 112 59 8
Totale 1.235